Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Organic Chemistry
|
October 24, 2001
A New and Efficient Solid Phase Synthesis of Hydroxamic Acids
Khehyong Ngu, Dinesh V. Patel
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2007
Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment
David S Weinstein, Wen Liu, Khehyong Ngu, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2011
Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase
Khehyong Ngu, David S Weinstein, Wen Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 20, 2003
Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1
Saleem Ahmad, Khehyong Ngu, Donald W Combs, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2005
Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase
David S Weinstein, Wen Liu, Zhengxiang Gu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
Saleem Ahmad, Khehyong Ngu, Keith J Miller, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor
Saleem Ahmad, William N Washburn, Andres S Hernandez, et al.
Journal of Medicinal Chemistry
|
April 17, 2008
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential
Saleem Ahmad, Cort S Madsen, Philip D Stein, et al.
Journal of Medicinal Chemistry
|
December 2, 2020
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches
Hai-Yun Xiao, Ning Li, James J-W Duan, et al.
Journal of Medicinal Chemistry
|
August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate
William N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Organic Chemistry
|
October 24, 2001
A New and Efficient Solid Phase Synthesis of Hydroxamic Acids
Khehyong Ngu, Dinesh V. Patel
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2007
Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment
David S Weinstein, Wen Liu, Khehyong Ngu, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2011
Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase
Khehyong Ngu, David S Weinstein, Wen Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 20, 2003
Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1
Saleem Ahmad, Khehyong Ngu, Donald W Combs, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2005
Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase
David S Weinstein, Wen Liu, Zhengxiang Gu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
Saleem Ahmad, Khehyong Ngu, Keith J Miller, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor
Saleem Ahmad, William N Washburn, Andres S Hernandez, et al.
Journal of Medicinal Chemistry
|
April 17, 2008
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential
Saleem Ahmad, Cort S Madsen, Philip D Stein, et al.
Journal of Medicinal Chemistry
|
December 2, 2020
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches
Hai-Yun Xiao, Ning Li, James J-W Duan, et al.
Journal of Medicinal Chemistry
|
August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate
William N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Page
of 1